A.BokenfohrR.McGannL
Cryan JF, ORiordan KJ, Sandhu K, Peterson V, Dinan TG
It is not a drug, supplement, or food, and it is not intended to diagnose, treat, cure, or prevent any disease
These are rare but more likely in patients with pre-existing cardiovascular conditions
Quick Answer: Zepbound (tirzepatide) does not list dysgeusia as a formal adverse effect, though some patients report taste changes that may be related to gastrointestinal side effects like nausea and reflux
Slimming pens face coverage hurdle in Brazil Despite booming demand for GLP-1 treatments, insurers and public health system resist adding them to obesity care The pace of growth for sales of GLP-1 hormone analogues in Brazila category that includes blockbusters Wegovy and Mounjarodepends on treatment protocols for obesity that account for multiple options